Epidemiology and outcomes of acute liver failure in Australia

doi:10.4254/wjh.v11.i7.586

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7702)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

493

WORD

379

HTML

3801

Figures (1-2)

341

Tables (1-3)

535

Sum=5549

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

813

Download

1337

Sum=2150

Jul 27, 2019 (publication date) through Feb 15, 2025

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jul 27, 2019; 11(7): 586-595
Published online Jul 27, 2019. doi: 10.4254/wjh.v11.i7.586

Table 1 Drugs and toxins implicated in cases of acute liver failure managed at the Victorian Liver Transplant Unit from 2002-2017

Drug/Toxins	Cases of ALF	Waitlisted for ELT	ELT
Drug/Toxins	(n = 101)	(n = 21)	(n = 13)
Paracetamol	84	11	3
Antibiotics	4	2	2
Amoxicillin/clavulanate (2), clarithromycin, isoniazid	4	2	2
Infliximab	2	2	2
Illicit drugs	4	1	1
LSD, injected buprenorphine, amphetamines, MDMA	4	1	1
NSAIDs	1	1	1
Amanita phalloides	1	1	1
Herbal medicines
Black cohosh herb, kava kava	2	2	2
Other
Moxonidine, fenofibrate, chlorambucil	3	1	1

ALF: Acute liver failure; ELT: Emergency liver transplantation; NSAIDs: Non-steroid anti-inflammatory drugs; LSD: Lysergic acid diethylamide; MDMA: Methylenedioxymethamphetamine; NSAIDs: Non-steroidal anti-inflammatory drugs

Citation: Hey P, Hanrahan TP, Sinclair M, Testro AG, Angus PW, Peterson A, Warrillow S, Bellomo R, Perini MV, Starkey G, Jones RM, Fink M, McClure T, Gow P. Epidemiology and outcomes of acute liver failure in Australia. World J Hepatol 2019; 11(7): 586-595
URL: https://www.wjgnet.com/1948-5182/full/v11/i7/586.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i7.586